Published in Gene Therapy Weekly, August 8th, 2002
Cardiac fibrosis and hypertrophy are hallmarks of human primary cardiomyopathy. These events, especially fibrosis formation, are believed to stem blood flow in the heart, generating increased injury. Hepatocyte growth factor (HGF), with antifibrosis and proangiogenic properties, could be used to ameliorate myocardial disease, given the results of a study performed on Syrian hamsters with genetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.